RAPAMYCIN-DERIVATE

European patent · EP3687999 · In force

Register entry

Publication number
EP3687999
Application number
EP18786408
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Sep 25, 2018
Published
Aug 5, 2020
Granted
Jan 3, 2024
Protection ends at the latest
Sep 24, 2038
Next annual fee due
Sep 30, 2027
IPC classes
C07D 498/18 (2006.01)
A61K 31/436 (2006.01)
A61P 19/00 (2006.01)
A61P 3/04 (2006.01)
A61P 9/10 (2006.01)
A61P 11/00 (2006.01)
A61P 25/16 (2006.01)
A61P 25/28 (2006.01)
A61P 35/00 (2006.01)
A61P 19/10 (2006.01)
A61P 37/00 (2006.01)
A61P 13/12 (2006.01)
A61P 25/02 (2006.01)
A61P 19/02 (2006.01)
A61P 9/12 (2006.01)
A61P 3/10 (2006.01)
A61P 31/10 (2006.01)
A61P 29/00 (2006.01)
C07F 9/32 (2006.01)
Priority
US 201762563312 P 26.09.2017
PCT application
PCT/IB2018/057422 25.09.2018
PCT publication
WO2019/064182 04.04.2019
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Oct 1, 2026

    Next annual fee due on

    Next annual fee due on
    30.09.2026 → 30.09.2027

    Published in Swissreg on 01.10.2026

  2. Oct 1, 2025

    Next annual fee due on

    Next annual fee due on
    30.09.2025 → 30.09.2026

    Published in Swissreg on 01.10.2025

  3. Jun 13, 2025

    Further processing requested

    Published in Swissreg on 13.06.2025

  4. Jun 13, 2025

    Status of protective title

    Status of protective title
    Cancelled → Active
    Next annual fee due on
    30.09.2024 → 30.09.2025
    Cancellation date
    25.04.2025 (removed)
    Cause for cancellation
    Non-payment of renewal fee (removed)

    Published in Swissreg on 13.06.2025

  5. Apr 25, 2025

    Deleted, fee unpaid

    Status of protective title
    Active → Cancelled
    Cancellation date
    25.04.2025
    Cause for cancellation
    Non-payment of renewal fee

    Published in Swissreg on 25.04.2025

  6. Nov 13, 2024

    Change

    Published in Swissreg on 13.11.2024

  7. Feb 13, 2024

    Agent entered

    Representative
    VALIPAT, c/o BOVARD LTD, Optingenstrasse 16, 3013 Bern

    Published in Swissreg on 13.02.2024

  8. Jan 3, 2024

    Granted

    Published in Swissreg on 03.01.2024

Parties

Holder

Novartis AG

Lichtstrasse 35, 4056 Basel

Agent

VALIPAT c/o BOVARD LTD

Optingenstrasse 16, 3013 Bern

Inventor

BONAZZI, Simone

Cambridge, MA 02139, US

SHAVLAKADZE, Tea

Cambridge, MA 02139, US

MIHALIC, Manuel

4002 Basel

GLASS, David Jonathan

Cambridge, MA 02139, US

ROGGO, Silvio

4002 Basel

PATTERSON, Andrew William

Cambridge, MA 02139, US

CONNOLLY, Michael

Cambridge, MA 02139, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.